Wird geladen...
Discordance between testosterone measurement methods in castrated prostate cancer patients
Failure to suppress testosterone below 0.7 nM in castrated prostate cancer patients is associated with poor clinical outcomes. Testosterone levels in castrated patients are therefore routinely measured. Although mass spectrometry is the gold standard used to measure testosterone, most hospitals use...
Gespeichert in:
| Veröffentlicht in: | Endocr Connect |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Bioscientifica Ltd
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6376995/ https://ncbi.nlm.nih.gov/pubmed/30673630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-18-0476 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|